181 related articles for article (PubMed ID: 8674449)
1. [Endocarditis caused by Staphylococcus lugdunensis leading to death].
Brander M; Aho R; Saarinen A
Duodecim; 1995; 111(5):452-4. PubMed ID: 8674449
[No Abstract] [Full Text] [Related]
2. Significance of Staphylococcus lugdunensis bacteremia: report of 28 cases and review of the literature.
Zinkernagel AS; Zinkernagel MS; Elzi MV; Genoni M; Gubler J; Zbinden R; Mueller NJ
Infection; 2008 Aug; 36(4):314-21. PubMed ID: 18648747
[TBL] [Abstract][Full Text] [Related]
3. Two successfully treated cases of Staphylococcus lugdunensis endocarditis.
Chatzigeorgiou KS; Ikonomopoulou C; Kalogeropoulou S; Siafakas N; Giannopoulos G; Antoniadou A; Tassios PT; Tarpatzi E; Giannitsioti E; Vlachakos D; Ikonomopoulos T; Petinaki E; Zerva L
Diagn Microbiol Infect Dis; 2010 Dec; 68(4):445-8. PubMed ID: 21094427
[TBL] [Abstract][Full Text] [Related]
4. Endocarditis due to Staphylococcus sciuri.
Hedin G; Widerström M
Eur J Clin Microbiol Infect Dis; 1998 Sep; 17(9):673-5. PubMed ID: 9832275
[No Abstract] [Full Text] [Related]
5. Staphylococcus lugdunensis endocarditis following cardiac catheterisation.
Matthews PC; Missouris CG; Jordaan J; Lessing MP
Int J Cardiol; 2008 Oct; 130(1):87-8. PubMed ID: 17689713
[TBL] [Abstract][Full Text] [Related]
6. Short-course therapy for right-side endocarditis due to Staphylococcus aureus in drug abusers: cloxacillin versus glycopeptides in combination with gentamicin.
Fortún J; Navas E; Martínez-Beltrán J; Pérez-Molina J; Martín-Dávila P; Guerrero A; Moreno S
Clin Infect Dis; 2001 Jul; 33(1):120-5. PubMed ID: 11389505
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic effect of ME1036 on endocarditis experimentally induced by methicillin-resistant Staphylococcus aureus.
Nagura J; Kijima K; Kurazono M; Takahata S; Sugano T; Tanaka Y; Hirai Y; Yamada K; Takayama Y; Shitara E; Yonezawa M
Antimicrob Agents Chemother; 2005 Aug; 49(8):3526-8. PubMed ID: 16048975
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of mitral MRSA endocarditis using daptomycin].
Senneville E; Beltrand E; Legout L; Leroy O; Fayad G
Med Mal Infect; 2008 Dec; 38 Spec No 2():13-5. PubMed ID: 19185204
[No Abstract] [Full Text] [Related]
9. Staphylococcus lugdunensis endocarditis with isolated tricuspid valve involvement.
Chung KP; Chang HT; Liao CH; Chu FY; Hsueh PR
J Microbiol Immunol Infect; 2012 Jun; 45(3):248-50. PubMed ID: 22041168
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis of treatment of methicillin-resistant Staphylococcus aureus bacteremia and endocarditis is a difficult issue.
Westling K
Clin Infect Dis; 2009 Sep; 49(5):699-701. PubMed ID: 19635027
[No Abstract] [Full Text] [Related]
11. Endocarditis caused by Staphylococcus lugdunensis.
Jones RM; Jackson MA; Ong C; Lofland GK
Pediatr Infect Dis J; 2002 Mar; 21(3):265-8. PubMed ID: 12005099
[TBL] [Abstract][Full Text] [Related]
12. Bacteriological outcome of combination versus single-agent treatment for staphylococcal endocarditis.
Drinković D; Morris AJ; Pottumarthy S; MacCulloch D; West T
J Antimicrob Chemother; 2003 Nov; 52(5):820-5. PubMed ID: 14519677
[TBL] [Abstract][Full Text] [Related]
13. Staphylococcus lugdunensis endocarditis after angiography.
Polenakovik H; Herchline T; Bacheller C; Bernstein J
Mayo Clin Proc; 2000 Jun; 75(6):656-7. PubMed ID: 10852432
[No Abstract] [Full Text] [Related]
14. Impact of empirical-therapy selection on outcomes of intravenous drug users with infective endocarditis caused by methicillin-susceptible Staphylococcus aureus.
Lodise TP; McKinnon PS; Levine DP; Rybak MJ
Antimicrob Agents Chemother; 2007 Oct; 51(10):3731-3. PubMed ID: 17664322
[TBL] [Abstract][Full Text] [Related]
15. Endocarditis caused by Staphylococcus aureus with reduced susceptibility to vancomycin.
Woods CW; Cheng AC; Fowler VG; Moorefield M; Frederick J; Sakoulas G; Meka VG; Tenover FC; Zwadyk P; Wilson KH
Clin Infect Dis; 2004 Apr; 38(8):1188-91. PubMed ID: 15095227
[TBL] [Abstract][Full Text] [Related]
16. Evidence of less severe aortic valve destruction after treatment of experimental staphylococcal endocarditis with vancomycin and dexamethasone.
Siaperas P; Pefanis A; Iliopoulos D; Katsarolis I; Kyroudi-Voulgari A; Donta I; Karayiannakos P; Giamarellou H
Antimicrob Agents Chemother; 2001 Dec; 45(12):3531-7. PubMed ID: 11709335
[TBL] [Abstract][Full Text] [Related]
17. Treatment failure of methicillin-resistant Staphylococcus aureus endocarditis with linezolid.
Corne P; Marchandin H; Macia JC; Jonquet O
Scand J Infect Dis; 2005; 37(11-12):946-9. PubMed ID: 16308242
[TBL] [Abstract][Full Text] [Related]
18. Staphylococcus lugdunensis: the coagulase-negative staphylococcus you don't want to ignore.
Babu E; Oropello J
Expert Rev Anti Infect Ther; 2011 Oct; 9(10):901-7. PubMed ID: 21973302
[TBL] [Abstract][Full Text] [Related]
19. Monitoring antimicrobial therapy in bacterial endocarditis.
Dornbusch K; Boman H; Henning C; Norén V; Cars O
Scand J Infect Dis Suppl; 1983; 41():173-6. PubMed ID: 6589755
[No Abstract] [Full Text] [Related]
20. Staphylococcus capitis prosthetic valve endocarditis: report of two rare cases and review of literature.
Nalmas S; Bishburg E; Meurillio J; Khoobiar S; Cohen M
Heart Lung; 2008; 37(5):380-4. PubMed ID: 18790338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
